your liver, kidneys, gut, lungs, lymphatic system, and skin work every day to process and remove waste products
adults treated for an overdose between 2017 and early 2026, found that patients who started a GLP-1 receptor agonist after their overdose had a 39% lower risk of a repeat overdose within three years compared to patients never prescribed one
Research news Danish register study presented at the European Congress on Obesity has associated glucagon-like peptide-1 receptor agonist treatment with a 26 per cent reduction in asthma exacerbations and lower use of reliever medication among adults with asthma and overweight, obesity or type 2 diabetes Novel research has linked the use of glucagon-like peptide-1 (GLP-1) receptor agonist drugs in people with asthma to a reduction in asthma exacerbations and a fall in the use of reliever inhalers
Wei S, Nguyen TT, Zhang Y, Ryu D, Gariani K
Paulescu published his results the following year and then took out a Romanian patent on his technique in April 1922